Practice Pearls

What can we help you find?
AML 8
Yehuda Deutsch, MD, and Amanda Brahim, PharmD, BCOP, BCPS, BCACP, review the risks and precautions taken with the available treatments of acute myeloid leukemia (AML).
 
AML
Amanda Brahim, PharmD, BCOP, BCPS, BCACP, discusses the members of her institution’s Pharmacy and Therapeutics (P&T) Committee who review acute myeloid leukemia treatments for formulary consideration.
AML
Amanda Brahim, PharmD, BCOP, BCPS, BCACP, shares treatments included on her institution’s formulary for acute myeloid leukemia [AML], and factors that impact the addition of treatments to the formulary.
onc
Experts in the area of acute myeloid leukemia discuss categorizing patients for treatment based on molecular testing results.
onc
Yehuda Deutsch, MD, discusses the cytogenetic tests used in acute myeloid leukemia (AML), and the importance of waiting for these results.
onc
Amanda Brahim, PharmD, BCOP, BCPS, BCACP, and Yehuda Deutsch, MD, review important laboratory and molecular tests used for diagnosing acute myeloid leukemia.
onc
Yehuda Deutsch, MD, and Amanda Brahim, PharmD, BCOP, BCPS, BCACP, review the risk factors for developing acute myeloid leukemia (AML) and the clinical presentation.
AML
A panel of experts in acute myeloid leukemia provide an overview of the disease state and its clinical features.
hepatitis c
A review of the common misconceptions of hepatitis C reviewed by the experts in the field.
syringe
Experts in the management of hepatitis C discuss transmission of the hepatitis C virus by sexual transmission and by tattoo parlors.
hepatitis c
The panel of experts in the management of hepatitis C discuss the syringe exchange programs in different states.
hep c
Hepatitis C specialists identify the different ways hepatitis C virus can be transmitted.